Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
19.47
+0.20 (1.04%)
Apr 30, 2025, 3:00 PM CST
SHA:603896 Revenue
Zhejiang Shouxiangu Pharmaceutical had revenue of 170.81M CNY in the quarter ending March 31, 2025, a decrease of -22.68%. This brings the company's revenue in the last twelve months to 641.59M, down -19.71% year-over-year. In the year 2024, Zhejiang Shouxiangu Pharmaceutical had annual revenue of 691.68M, down -11.81%.
Revenue (ttm)
641.59M
Revenue Growth
-19.71%
P/S Ratio
6.02
Revenue / Employee
573.87K
Employees
1,118
Market Cap
3.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 691.68M | -92.66M | -11.81% |
Dec 31, 2023 | 784.35M | -44.72M | -5.39% |
Dec 31, 2022 | 829.07M | 61.93M | 8.07% |
Dec 31, 2021 | 767.14M | 131.09M | 20.61% |
Dec 31, 2020 | 636.05M | 89.29M | 16.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |